PBLS ▼ -7.9% - Parabilis Medicines, Inc.
$PBLS - Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
24-OCT-2026 08:45 AM ET
Share this post
More filings for $PBLS
PBLS ▲ +2.9% - Parabilis Medicines, Inc.Oct 19, 2026PBLS ▲ +0.6% - Parabilis Medicines, Inc.Oct 14, 2026PBLS ▲ +0.9% - Parabilis Medicines, Inc.Sep 1, 2026PBLS - Parabilis Medicines, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026PBLS - Parabilis Medicines, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026
View full $PBLS filing history →💬 Comments
Loading comments…
Leave a comment